|
Status |
Public on Nov 14, 2016 |
Title |
#1-SU042 AML |
Sample type |
genomic |
|
|
Source name |
Primary AML_SU042
|
Organism |
Homo sapiens |
Characteristics |
sample group: Primary AML subject: SU042
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was isolated from the indicated populations using standard protocols (Qiagen Inc)
|
Label |
Cy3 and Cy5
|
Label protocol |
Standard Ilumina protocol
|
|
|
Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridized to Infinium Methylation 450 arrays using standard Illumina protocol
|
Scan protocol |
Arrays were scanned using recommened Illumina settings
|
Data processing |
Beta values were calculated with Minfi v 1.12.0 (Aryee et al 2014)
|
|
|
Submission date |
Nov 10, 2016 |
Last update date |
Nov 16, 2016 |
Contact name |
Andrew Gentles |
Organization name |
Stanford University
|
Street address |
1201 Welch Road
|
City |
Stanford |
State/province |
CA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE89776 |
Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of Subclones [methylation] |
GSE89778 |
Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of Subclones |
|